Latest news about Intellectual Property

5. March 2019
International Intellectual Property

Apple has won in the Federal Patent Court. The focus was on Apple's DE patent on display orientation, i.e. the determination and modification of the display depending on whether the user holds his smartphone upright or sideways. This important basic patent was filed as part of the PCT application and was rejected by the DPMA.

read more
4. March 2019
International Intellectual Property

The French manufacturer of the well-known MIKADO chocolate bars has won an appeal before the European Court of Justice. The protected earlier 3 D colour mark combined with the brand name MIKADO was recognised as a mark from the shape of the product and as a necessary proof of genuine use of the earlier mark.

read more
1. March 2019
International Intellectual Property

In yesterday's judgment of the ECJ in the trademark proceedings concerning the cosmetics brand SO 'BiO ētic, the focus was on the assessment of the court in the judgment of June 2017 in these trademark proceedings. The CJEU disregarded the established case-law on the likelihood of confusion between trademarks and the reputation of an earlier trademark, according to the action.

read more
26. February 2019
Healthcare & Lifesciences

U.S. company Amgen has successfully defended two patents related to its cholesterol drug Repatha. The U.S. court in Delaware yesterday confirmed the validity of the patents at the center of the patent dispute with Sanofi and Regeneron.

read more
26. February 2019
International Intellectual Property

Word marks must not be descriptive, therefore new word creations as word marks are popular. The German BPatG now rejected the word creation ColorPlugin as a trademark registration and specified special features in word formation with regard to protectability and distinctiveness.

read more
25. February 2019
Healthcare & Lifesciences

Protection by a supplementary protection certificate for the new formulation of an active substance is important for the development of new drugs. The granting of several SPCs on the basis of the same patent has been judged in the case law of recent years.

read more
Kontakt / Contact
close slider
To be able to use this offer, you have to consent to the storage of your personal data. We will treat your personal data as strictly confidential and will only use them to improve our company’s marketing. Read more in our privacy policy. With consenting to the storage of your personal data, you also consent that we use your email address to send further information to you which might be of interest for you.
The system is using cookies to enable analysis of this website’s users and their interests.